DE69940793D1 - Chimärisches Gen, dass für die antigenischen Determinanten von vier Proteinen aus L. Infantum kodiert - Google Patents
Chimärisches Gen, dass für die antigenischen Determinanten von vier Proteinen aus L. Infantum kodiertInfo
- Publication number
- DE69940793D1 DE69940793D1 DE69940793T DE69940793T DE69940793D1 DE 69940793 D1 DE69940793 D1 DE 69940793D1 DE 69940793 T DE69940793 T DE 69940793T DE 69940793 T DE69940793 T DE 69940793T DE 69940793 D1 DE69940793 D1 DE 69940793D1
- Authority
- DE
- Germany
- Prior art keywords
- proteins
- gene encoding
- chimeric gene
- infantum
- antigenic determinants
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 241000222697 Leishmania infantum Species 0.000 title abstract 2
- 230000000890 antigenic effect Effects 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 206010047505 Visceral leishmaniasis Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 208000004554 Leishmaniasis Diseases 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11382598P | 1998-12-23 | 1998-12-23 | |
| CA2256124A CA2256124C (en) | 1998-12-23 | 1998-12-23 | Chimeric gene formed of the dna sequences that encode the antigenic determinants of four proteins of l. infantum, and protein encoded by said gene, and pharmaceutical composition useful for preventing and/or treating leishmaniosis in animals or humans |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE69940793D1 true DE69940793D1 (de) | 2009-06-04 |
Family
ID=25680668
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69931518T Expired - Lifetime DE69931518T2 (de) | 1998-12-23 | 1999-12-23 | Chimäres Gen, das für die antigenischen Determinaten von vier Proteinen aus L. Infantum kodiert |
| DE69940793T Expired - Lifetime DE69940793D1 (de) | 1998-12-23 | 1999-12-23 | Chimärisches Gen, dass für die antigenischen Determinanten von vier Proteinen aus L. Infantum kodiert |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69931518T Expired - Lifetime DE69931518T2 (de) | 1998-12-23 | 1999-12-23 | Chimäres Gen, das für die antigenischen Determinaten von vier Proteinen aus L. Infantum kodiert |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1141305B1 (de) |
| CN (1) | CN1158387C (de) |
| AT (2) | ATE429498T1 (de) |
| AU (1) | AU759316B2 (de) |
| BE (1) | BE2016C049I2 (de) |
| BG (1) | BG65569B1 (de) |
| BR (1) | BRPI9916549B8 (de) |
| CY (3) | CY1105331T1 (de) |
| CZ (1) | CZ20012360A3 (de) |
| DE (2) | DE69931518T2 (de) |
| DK (1) | DK1141305T3 (de) |
| ES (2) | ES2273519T3 (de) |
| HR (1) | HRP20010554A2 (de) |
| HU (1) | HUP0104743A3 (de) |
| IL (2) | IL143956A0 (de) |
| LU (1) | LU93259I2 (de) |
| MX (1) | MXPA01006548A (de) |
| NL (1) | NL300830I2 (de) |
| PT (2) | PT1141305E (de) |
| SI (1) | SI1624063T1 (de) |
| TR (1) | TR200102655T2 (de) |
| WO (1) | WO2000039298A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6613337B1 (en) * | 1997-02-12 | 2003-09-02 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| ES2169995B1 (es) * | 2000-04-17 | 2003-12-01 | Leti Lab | Composicion a base de la proteina lip2a y su uso en la preparacion de un medicamento para suscitar una respuesta inmune contra un antigeno. |
| US6673351B1 (en) | 2001-03-16 | 2004-01-06 | Astralis, Llc | Compositions and methods for the treatment and clinical remission of psoriasis |
| WO2006058243A2 (en) * | 2004-11-24 | 2006-06-01 | Yale University | Leishmania antigens and related compositions and uses |
| CA2712475A1 (en) * | 2008-01-18 | 2009-07-23 | Laboratorios Leti, S.L. Unipersonal | Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant |
| CA2767865A1 (en) * | 2009-07-13 | 2011-01-20 | Laboratorios Leti, S.L. | Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (rpe) |
| SA110310855B1 (ar) | 2009-11-13 | 2014-09-16 | Laboratories Leti S L Unipersonal | استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي |
| BR102019003639A2 (pt) * | 2019-02-22 | 2021-11-16 | Fundação Oswaldo Cruz | Proteína quimérica, seu método para produção e uso, bem como molécula de ácido nucleico, cassete de expressão, vetor de expressão, célula hospedeira, composição para diagnóstico de leishmaniose, kit de diagnóstico de leishmaniose e método de diagnóstico de leishmaniose in vitro |
| ES2795149B2 (es) | 2020-06-08 | 2022-07-04 | Univ Madrid Complutense | Quimera sintetica multiepitopica como vacuna y tratamiento frente a leishmaniosis en mamiferos |
| CN112662694A (zh) * | 2020-12-25 | 2021-04-16 | 康九生物科技(长春)有限公司 | 一种麦芽糖结合蛋白、麦芽糖结合蛋白表达载体、重组工程菌及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0703295A1 (de) * | 1994-09-26 | 1996-03-27 | Institut Pasteur | GP63-Fusionsprotein exprimierendes, rekombinantes, BCG enthaltende Impfstoffzusammensetzung |
| US5912166A (en) * | 1995-04-21 | 1999-06-15 | Corixa Corporation | Compounds and methods for diagnosis of leishmaniasis |
| ES2133236B1 (es) * | 1997-06-27 | 2000-04-16 | Leti Lab | Gen quimerico formado por las secuencias de dna que codifican los determinantes antigenicos de cuatro proteinas de l. infantum, aplicable para el diagnostico serologico de leishmaniosis canina y proteina obtenida. |
-
1999
- 1999-12-23 AT AT05109393T patent/ATE429498T1/de not_active IP Right Cessation
- 1999-12-23 CN CNB998163066A patent/CN1158387C/zh not_active Expired - Lifetime
- 1999-12-23 DE DE69931518T patent/DE69931518T2/de not_active Expired - Lifetime
- 1999-12-23 MX MXPA01006548A patent/MXPA01006548A/es active IP Right Grant
- 1999-12-23 CZ CZ20012360A patent/CZ20012360A3/cs unknown
- 1999-12-23 WO PCT/EP1999/010441 patent/WO2000039298A1/en active IP Right Grant
- 1999-12-23 SI SI9931029T patent/SI1624063T1/sl unknown
- 1999-12-23 PT PT99967987T patent/PT1141305E/pt unknown
- 1999-12-23 ES ES99967987T patent/ES2273519T3/es not_active Expired - Lifetime
- 1999-12-23 EP EP99967987A patent/EP1141305B1/de not_active Expired - Lifetime
- 1999-12-23 HU HU0104743A patent/HUP0104743A3/hu unknown
- 1999-12-23 DE DE69940793T patent/DE69940793D1/de not_active Expired - Lifetime
- 1999-12-23 DK DK99967987T patent/DK1141305T3/da active
- 1999-12-23 TR TR2001/02655T patent/TR200102655T2/xx unknown
- 1999-12-23 BR BRPI9916549A patent/BRPI9916549B8/pt not_active IP Right Cessation
- 1999-12-23 ES ES05109393T patent/ES2326174T3/es not_active Expired - Lifetime
- 1999-12-23 IL IL14395699A patent/IL143956A0/xx unknown
- 1999-12-23 AT AT99967987T patent/ATE327332T1/de active
- 1999-12-23 PT PT05109393T patent/PT1624063E/pt unknown
- 1999-12-23 AU AU24342/00A patent/AU759316B2/en not_active Expired
-
2001
- 2001-06-24 IL IL143956A patent/IL143956A/en not_active IP Right Cessation
- 2001-07-23 BG BG105725A patent/BG65569B1/bg unknown
- 2001-07-23 HR HR20010554A patent/HRP20010554A2/hr not_active Application Discontinuation
-
2006
- 2006-08-24 CY CY20061101190T patent/CY1105331T1/el unknown
-
2009
- 2009-07-14 CY CY20091100739T patent/CY1109221T1/el unknown
-
2016
- 2016-09-22 NL NL300830C patent/NL300830I2/nl unknown
- 2016-10-06 BE BE2016C049C patent/BE2016C049I2/nl unknown
- 2016-10-06 LU LU93259C patent/LU93259I2/fr unknown
- 2016-10-20 CY CY2016033C patent/CY2016033I2/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU93259I2 (fr) | LETIFEND (Protein Q) | |
| DE60121808D1 (de) | Verwendung eines polypeptids, welches die extrazelluläre domäne von il-20ra und il-20rb enthält, zur behandlung von entzündungen | |
| ATE169304T1 (de) | Biologisch aktive peptide aus funktionellen domaenen des bakteriziden/ die permeabilitaet erhoehenden proteins und ihre verwendung | |
| ATE389724T1 (de) | Menschliche dnase i hyperaktive varianten | |
| BG104266A (en) | Aminoterminally incised mcp-2 as haemokin antagonists | |
| ATE304052T1 (de) | Humane checkpointkinase, hcds1, zusammensetzungen und verfahren | |
| YU79202A (sh) | Peptid koji modulira trombopoetinski receptor | |
| DE60035693D1 (de) | Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten | |
| DE69534471D1 (de) | Peptide, die fähig sind die sh3-domäne des gap-proteins zu binden, ihre kodierende dns, ihre zubereitung und verwendung | |
| TR200100637T2 (tr) | Yeni doğal ürün türevleri | |
| MXPA04001986A (es) | Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad. | |
| DE69913380D1 (de) | Zusammensetzung zur behandlung von periodontalen erkrankungen | |
| PL336897A1 (en) | Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts | |
| DE59410423D1 (de) | Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose | |
| YU51601A (sh) | Himerni gen koji kodira antigene determinante četiri proteina l.infantum | |
| EE05139B1 (et) | Peptiid, seda kodeeriv geen, reagent ja reaktiivikomplekt riketsioosi tuvastamiseks ning peptiidi sisaldav vaktsiin | |
| DK0811068T3 (da) | Humane DNase I varianter | |
| DE60129228D1 (de) | Humane 7-transmembranproteine und dafür codierende polynukleotide | |
| ATE480560T1 (de) | Zusammensetzung zur behandlung von periodontalen erkrankungen | |
| DE69813620D1 (de) | Verwendung von citrullin enthaltenden peptiden, die von filaggrin abstammen, zur behandlung von autoimmunkrankheiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |